VFVanessa Fein

Vanessa Fein

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Vanessa Fein has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Alicia Hauke

    Fraunhofer Institute for Integrated Systems and Device Technology, 91058 Erlangen, Germany

    1 shared publication
  • Anne Schlegtendal

    Department of Paediatric Pneumology, University Children’s Hospital, Ruhr-University Bochum, Bochum, Germany

    1 shared publication
  • Christoph Maier

    Department of Paediatric Pneumology, University Children’s Hospital, Ruhr-University Bochum, Bochum, Germany

    1 shared publication
  • Christoph Maier

    University Children´s Hospital, Katholisches Klinikum Bochum, Ruhr-University Bochum , Bochum

    1 shared publication
  • Cordula Koerner-Rettberg

    Department of Paediatrics, Marienhospital Wesel, Teaching Hospital of the University of Münster, Wesel, Germany

    1 shared publication
  • Folke Brinkmann

    Department of Paediatric Pneumology, University Children’s Hospital, Ruhr-University Bochum, Bochum, Germany

    1 shared publication

Latest Publications

  • Does the type of bacterial colonization in lower airways affect the lung function in patients with Primary Ciliary Dyskinesia (PCD)?

    by Vanessa Fein, Anne Schlegtendal, Christoph Maier, Cordula Koerner-Rettberg, Folke Brinkmann

    Backgound: The pattern of bacterial colonization in the lower airways of patients with PCD changes over time. Studies show that younger patients are predominantly colonized with H. influenzae and M. catarrhalis whereas adults show P. aeruginosa significantly more often. The number of different pathogens increases with the patients’ age. P. aeruginosa is associated with a lower FEV1 and a young age of diagnosis reduces the risk of colonization with this pathogen. Studies evaluating the long-time effect of the colonization pattern on lung function in PCD are rare. Aims: The aim of our study is to evaluate whether a chronic or intermittent bacterial colonization in PCD with different pathogens leads to a decrease in lung function and more frequent exacerbations. Methods: We performed a retrospective analysis of microbiological results, clinical data and lung function parameters from 03/2010 - 12/2020. Results: We included 44 patients (22 female, 22 male) who regularly attended the Paediatric Pneumology Outpatient Department. Medium follow up period was 7.7 years and the medium number of visits 38. Medium age of patients at appointments was 13.6 years. The most frequent pathogen found in the 1398 available microbiological samples was H. influenzae (262x, 18.74%), followed by S. aureus (148x, 10.59%), M. catarrhalis (65x, 4.65%) and P. aeruginosa (51x, 3.65%). In the following analysis, we evaluate the lung function parameters and correlate them with colonization patterns. A preliminary evaluation suggests that the impact of bacterial colonization on the course of lung function in patients with PCD is more individual than in CF.

  • Open Access

    Screen-Printed Sensor for Low-Cost Chloride Analysis in Sweat for Rapid Diagnosis and Monitoring of Cystic Fibrosis

    by Alicia Hauke, Susanne Oertel, Leona Knoke, Vanessa Fein, Christoph Maier, Folke Brinkmann, Michael P. M. Jank

    Analysis of sweat chloride levels in cystic fibrosis (CF) patients is essential not only for diagnosis but also for the monitoring of therapeutic responses to new drugs, such as cystic fibrosis transmembrane conductance regulator (CFTR) modulators and potentiators. Using iontophoresis as the gold standard can cause complications like burns, is uncomfortable, and requires repetitive hospital visits, which can be particularly problematic during a pandemic, where distancing and hygiene requirements are increased; therefore, it is necessary to develop fast and simple measures for the diagnosis and monitoring of CF. A screen-printed, low-cost chloride sensor was developed to remotely monitor CF patients. Using potentiometric measurements, the performance of the sensor was tested. It showed good sensitivity and a detection limit of 2.7 × 10−5 mol/L, which covered more than the complete concentration range of interest for CF diagnosis. Due to its fast response of 30 s, it competes well with standard sensor systems. It also offers significantly reduced costs and can be used as a portable device. The analysis of real sweat samples from healthy subjects, as well as CF patients, demonstrates a proper distinction using the screen-printed sensor. This approach presents an attractive remote measurement alternative for fast, simple, and low-cost CF diagnosis and monitoring